Stanford scientists developed a novel strategy that uses resting-state functional connectivity magnetic resonance imaging (rs-fMRI) to determine whether a person will respond to treatment for depression.
Stanford researchers develop a surgical technique to access the optical nerve head from tunneling through the suprachoroidal space (SCS) for drug delivery applications.
A Stanford inventor has developed a soft grommet/eyelet to load share and prevent suture pull-through of the repair stitch and a device to pass the eyelet.
Stanford researchers have developed a compact, scalable electronic readout that can multiplex 24 or more fast outputs of each 6x4 SiPM array to only 1 timing channel per detector layer unit.
Stanford scientists developed a comprehensive, minimally invasive, dual-catheter pulsed field device that utilizes a rapid and simple integrated mapping/ablation strategy for the treatment of Atrial Fibrillation.
Researchers at Stanford and UCSF have discovered a strong association between serious, potentially fatal, delayed hypersensitivity reactions that occur in a subset of patients exposed to IL-1/IL-6 inhibitors and HLA-DRB1*15 alleles that are common across ancestries.
Researchers at Stanford previously described a method under Stanford Docket S17-020 for introducing a large number of gene edits in parallel, termed Multiplexed Accurate Genome Editing with Short, Trackable, Integrated Cellular barcodes (MAGESTIC).
Researchers at Stanford and the European Molecular Biology Laboratory (EMBL) have discovered an improved embodiment of bacterial retron-based CRISPR gene editing in mammalian cells.
Stanford researchers have developed a geometric deep learning based novel method to aid in identification and discovery of novel drug scaffolds as well as to optimize known scaffolds, as a means to combat the major challenge in drug discovery.